[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338410-105":59,"doc-detail-338410-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bladder-cancer-treatments-in-the-age-of-personalized-medicine-a-comprehensive-review-of-potential-radiosensitivity-biomarkers","Bladder Cancer Treatments in the Age of Personalized Medicine - A Comprehensive Review of Potential Radiosensitivity Biomarkers","","Bladder cancer is among the most frequently diagnosed cancers in men. While cystectomy remains central, advances in radiotherapy and chemotherapy support bladder-preserving approaches that may improve quality of life. Approximately 20% of patients still need salvage cystectomy due to tumor radioresistance, highlighting the need for radiosensitivity predictive assays. Radiation response depends on DNA double-strand breaks, repair activation, tumor microenvironment, cell death, immune responses, and proliferation signals. This review summarizes studies on bladder cancer radiosensitivity and evaluates biomarkers for developing predictive assays.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bladder-cancer-treatments-in-the-age-of-personalized-medicine-a-comprehensive-review-of-potential-radiosensitivity-biomarkers/338410/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bladder-cancer-treatments-in-the-age-of-personalized-medicine-a-comprehensive-review-of-potential-radiosensitivity-biomarkers/338410.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is a radiosensitivity predictive assay needed in bladder cancer care?","Question",{"text":112,"@type":113},"About 20% of patients may still require salvage cystectomy due to tumor radioresistance. Predictive assays could help identify patients likely to respond to bladder-preserving radiotherapy-based strategies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What mechanisms drive tumor response to radiotherapy?",{"text":117,"@type":113},"Radiotherapy primarily induces DNA damage through DNA double-strand breaks, which can alter outcomes if unrepaired. Tumor response also involves DNA repair pathways, tumor microenvironment, cell death pathways, immune responses, and proliferation-related receptors.",{"name":119,"@type":110,"acceptedAnswer":120},"Which treatments are described as standard and alternative approaches for muscle-invasive bladder cancer?",{"text":121,"@type":113},"Radical cystectomy with pelvic lymph node dissection remains standard for muscle-invasive disease. Bladder-preserving strategies combine maximal TURBT with radiotherapy and chemotherapy to improve quality of life.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338410,1790831140,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Bladder Cancer Treatments in the Age of Personalized Medicine: A Comprehensive Review of Potential Radiosensitivity Biomarkers  \nCharbel Feghaly1*, Rafka Challita2* , Hanine Bou Hadir1,  \nTala Mobayed1, Tarek Al Bitar1, Mohammad Harbi2 , Hala Ghorayeb2 , Rana El-Hassan2 and Larry Bodgi1,2 ,3  \n1Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. 2 Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut, Lebanon. 3 U1296 Unit, “Radiation: Defense, Health and Environment”, Centre Léon-Bérard, Inserm, Lyon, France.  \nBiomarker Insights Volume 19: 1–19  \n© The Author(s) 2024  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/11772719241297168](DOI: 10.1177/11772719241297168)  \nABSTRACT: Bladder cancer is one of the most frequently diagnosed cancers in men. While cystectomy remains the primary treatment, advancesin radiotherapy and chemotherapy have highlighted the value of bladder-preserving strategies, which can also enhance patients’ quality of life. Despise these advances, around 20% of patients may still require salvage cystectomy due to tumor radioresistance. This underscores the need to develop radiosensitivity predictive assays. Radiotherapy acts by inducing DNA damage, primarily through DNA double-strand breaks, which can significantly affect treatment outcomes if left unrepaired. In addition to activating DNA repair pathways, the response to radiation also involves the tumor microenvironment, cell death pathways, immune responses and different types of cell death and proliferation receptors. In recent years, personalized medicine, which tailors treatments to individual patients, has gained increasing attention in cancer care. The development of chemo-and radiosensitivity predictive assays has become a key focus of cancer research. Despite the potential impact of such assayson bladder cancer treatment, there is still no reliable test that can help clinicians and informs patients in choosing the best treatment. This review aims to highlight studies that attempted to characterize bladder cancer radiosensitivity and to discuss the potential biomarkers that could be used to develop bladder cancer radiosensitivity predictive assays.  \nKeywoRdS: Bladder cancer, cystectomy, radiotherapy, chemoradiotherapy, radiosensitivity, predictive assays  \nReCeIVed: June 26, 2024. ACCePTed: October 17, 2024.  \nTyPe: Review Article  \nCoRReSPoNdING AUTHoR: Larry Bodgi, Department of Radiation Oncology, American University of Beirut Medical Center, PO Box 11-0236, Riad El-Solh 1107 2020, BeirutLebanon. Email: [Lb38@aub.edu.lb](Lb38@aub.edu.lb)  \n\n| Introduction\u003Cbr>Bladder cancer (BC) is one of the most common cancers worldwide, particularly among males. In 2022, it was the sixth most diagnosed cancer in this group, with 471 293 new cases, and the ninth most fatal, resulting in over 165 672 deaths.1 This malignant disease is categorized into non-muscle invasive (NMIBC) and muscle-invasive (MIBC), with the latter requiring aggressive treatments.\u003Cbr>Radical cystectomy (RC), whether open or robotic, combined with bilateral pelvic lymph node dissection, remains the standard treatment for MIBC. However, this approach significantly reduces quality of life, leading to reduced bladder capacity, testosterone depletion, sexual dysfunction, bowel incontinence, and increased risks of colon and colorectal cancers, as well as chronic kidney.3,4 Therefore, a bladder-preserving strategy was developed. It is based on maximal transurethral removal of bladder tumor (TURBT) followed by the combination of radiotherapy (RT) and chemotherapy (CT) .2-4\u003Cbr>This highlights the need to both radiobiologically characterize MIBC and develop MIBC-specific radiosensitivity predictive assays.5,6\u003Cbr>In recent years, many studies have attempted to enhance personalized cancer therapy by focusing on","cbCaisx84ZYnxYK4","https://ap.wps.com/l/cbCaisx84ZYnxYK4","pdf",1029476,"English","# Introduction\n## Bladder Cancer Diagnosis and Treatments\n# Conclusion\n## Biomarker and assay perspectives","[{\"question\":\"Why is a radiosensitivity predictive assay needed in bladder cancer care?\",\"answer\":\"About 20% of patients may still require salvage cystectomy due to tumor radioresistance. Predictive assays could help identify patients likely to respond to bladder-preserving radiotherapy-based strategies.\"},{\"question\":\"What mechanisms drive tumor response to radiotherapy?\",\"answer\":\"Radiotherapy primarily induces DNA damage through DNA double-strand breaks, which can alter outcomes if unrepaired. Tumor response also involves DNA repair pathways, tumor microenvironment, cell death pathways, immune responses, and proliferation-related receptors.\"},{\"question\":\"Which treatments are described as standard and alternative approaches for muscle-invasive bladder cancer?\",\"answer\":\"Radical cystectomy with pelvic lymph node dissection remains standard for muscle-invasive disease. Bladder-preserving strategies combine maximal TURBT with radiotherapy and chemotherapy to improve quality of life.\"}]","Bladder Cancer Treatments in the Age of Personalized Medicine - A Comprehensive Review of Potential Radiosensitivity Biomarkers | PDF",1790023534,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab167b5553bdea76d9a4a13675bb4110.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/689fcc6f4d4fed4919aa4140a70fb737.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d0972e9a833b90baf7e65cc1b49740b.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf81cef7191947b5b31104e9bb54a490.webp",980,1385]